UnitedHealth Aktie 1078451 / US91324P1021
600.79
USD
23.79
USD
4.12%
20.11.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
UnitedHealth Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | UnitedHealth Inc. | 1.38 | 7.29 | USD |
| 2022 | UnitedHealth Inc. | 1.21 | 6.40 | USD |
| 2021 | UnitedHealth Inc. | 1.12 | 5.60 | USD |
| 2020 | UnitedHealth Inc. | 1.38 | 4.83 | USD |
| 2019 | UnitedHealth Inc. | 1.41 | 4.14 | USD |
| 2018 | UnitedHealth Inc. | 1.38 | 3.45 | USD |
| 2017 | UnitedHealth Inc. | 1.30 | 2.88 | USD |
| 2016 | UnitedHealth Inc. | 1.48 | 2.38 | USD |
| 2015 | UnitedHealth Inc. | 1.59 | 1.88 | USD |
| 2014 | UnitedHealth Inc. | 1.39 | 1.41 | USD |
Gewinn je Aktie- UnitedHealth
| 10.7 17 | 12.2 18 | 14.3 19 | 16.0 20 | 18.1 21 | 21.2 22 | 23.9 23 |
Umsatz je Aktie- UnitedHealth
| 204 17 | 230 18 | 251 19 | 268 20 | 301 21 | 339 22 | 392 23 |
KGV- UnitedHealth
| 20.6 17 | 20.4 18 | 20.5 19 | 21.9 20 | 27.8 21 | 25.0 22 | 22.1 23 |
UnitedHealth Inc.: Die Aktie (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 10.72 | 12.19 | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 |
| Gewinn je Aktie unverwässert | 10.95 | 12.45 | 14.55 | 16.23 | 18.33 | 21.47 | 24.12 |
| Gewinn je Aktie verwässert | 10.72 | 12.19 | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 |
| Dividende pro Aktie | 2.88 | 3.45 | 4.14 | 4.83 | 5.60 | 6.40 | 7.29 |
| Gesamtdividendenausschüttung in Mio. | 2’773.00 | 3’320.00 | 3’932.00 | 4’584.00 | 5’280.00 | 5’991.00 | 6’761.00 |
UnitedHealth Inc.: Unternehmenskennzahlen (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 204.22 | 230.16 | 250.68 | 267.58 | 300.83 | 339.31 | 392.12 |
| KGV (Jahresendkurs, EPS unverwässert) | 20.57 | 20.43 | 20.52 | 21.88 | 27.77 | 25.03 | 22.06 |
| KGV (Jahresendkurs, EPS verwässert) | 20.57 | 20.43 | 20.52 | 21.88 | 27.77 | 25.03 | 22.06 |
| KGV (Jahresendkurs) | 20.57 | 20.43 | 20.52 | 21.88 | 27.77 | 25.03 | 22.06 |
| Dividendenrendite Jahresende in % | 1.30 | 1.38 | 1.41 | 1.38 | 1.12 | 1.21 | 1.38 |
| Eigenkapitalquote in % | 36.94 | 36.46 | 35.17 | 35.15 | 35.45 | 34.50 | 35.53 |
| Fremdkapitalquote in % | 63.06 | 63.54 | 64.83 | 64.85 | 64.55 | 65.50 | 64.47 |
UnitedHealth Inc.: GuV (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 201’159.00 | 226’247.00 | 242’155.00 | 257’141.00 | 287’597.00 | 322’343.00 | 367’809.00 |
| Umsatzveränderung in % | 8.83 | 12.47 | 7.03 | 6.19 | 11.84 | 12.08 | 14.10 |
| Bruttoergebnis vom Umsatz | - | - | - | - | - | - | - |
| Bruttoergebnisveränderung in % | - | - | - | - | - | - | - |
| Operatives Ergebnis | 15’209.00 | 17’344.00 | 19’685.00 | 22’405.00 | 23’970.00 | 26’616.00 | 28’545.00 |
| Veränderung Operatives Ergebnis in % | 17.63 | 14.04 | 13.50 | 13.82 | 6.99 | 11.04 | 7.25 |
| Ergebnis vor Steuern | 14’023.00 | 15’944.00 | 17’981.00 | 20’742.00 | 22’310.00 | 26’343.00 | 29’112.00 |
| Veränderung Ergebnis vor Steuern in % | 18.21 | 13.70 | 12.78 | 15.36 | 7.56 | 18.08 | 10.51 |
| Ergebnis nach Steuer | 10’558.00 | 11’986.00 | 13’839.00 | 15’403.00 | 17’285.00 | 20’120.00 | 22’381.00 |
| Veränderung Ergebnis nach Steuer in % | 50.46 | 13.53 | 15.46 | 11.30 | 12.22 | 16.40 | 11.24 |
UnitedHealth Inc.: Bilanz (in Mio. USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 88’808 | 97’995 | 114’595 | 130’141 | 139’275 | 163’955 | 179’496 |
| Langzeit Gesamtverbindlichk. pro Aktie | - | - | - | - | - | - | - |
| Eigenkapital | 52’022 | 56’227 | 62’162 | 70’539 | 76’479 | 86’347 | 98’919 |
| Veränderung Eigenkapital in % | 24.83 | 8.20 | 11.45 | 13.67 | 9.57 | 8.38 | 14.12 |
| Bilanzsumme | 140’830 | 154’222 | 176’757 | 200’680 | 215’754 | 250’302 | 278’415 |
| Veränderung Bilanzsumme in % | 12.63 | 9.51 | 14.61 | 13.53 | 7.51 | 16.01 | 11.23 |
UnitedHealth Inc.: Sonstige Angaben (in USD)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 10.95 | 12.45 | 14.55 | 16.23 | 18.33 | 21.47 | 24.12 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 48.59 | 13.64 | 16.92 | 11.54 | 12.93 | 17.15 | 12.32 |
| Gewinn je Aktie (verwässert) | 10.72 | 12.19 | 14.33 | 16.03 | 18.08 | 21.18 | 23.86 |
| Veränderung Gewinn je Aktie (verwässert) in % | 47.87 | 13.76 | 17.49 | 11.88 | 12.81 | 17.14 | 12.66 |
| Anzahl Mitarbeiter | 260’000 | 300’000 | 325’000 | 330’000 | 350’000 | 400’000 | 440’000 |
| Veränderung Anzahl Mitarbeiter in % | 13.04 | 15.38 | 8.33 | 1.54 | 6.06 | 14.29 | 10.00 |
UnitedHealth Inc. Termine
| Unternehmen | Event | Datum |
|---|---|---|
| UnitedHealth Inc. | Quartalszahlen | 15.01.2025 |
| UnitedHealth Inc. | Quartalszahlen | 22.04.2025 |
| UnitedHealth Inc. | Quartalszahlen | 16.07.2025 |
| UnitedHealth Inc. | Quartalszahlen | 21.10.2025 |
UnitedHealth Inc. vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 15.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 16.07.2024 |
| Hauptversammlung | Annual General Meeting | 03.06.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 16.04.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 12.01.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 13.10.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 14.07.2023 |
| Hauptversammlung | Annual General Meeting | 05.06.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 14.04.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 13.01.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 14.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 15.07.2022 |
| Hauptversammlung | Annual General Meeting | 06.06.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 14.04.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 19.01.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99.77 |
| The Vanguard Group, Inc. | 9.11 |
| Vanguard Group, Inc. (Subfiler) | 8.79 |
| State Street Corp. | 4.95 |
| Vanguard Total Stock Market ETF | 3.18 |
| Capital Research & Management Co. (World Investors) | 2.85 |
| BlackRock Fund Advisors | 2.79 |
| Vanguard 500 Index Fund | 2.63 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 2.57 |
| Wellington Management Co. LLP (Wellington Breakout) | 2.53 |
| Fidelity Management & Research Co. LLC | 2.46 |
| BlackRock Institutional Trust Co. NA | 2.19 |
| Geode Capital Management LLC | 2.13 |
| Capital Research & Management Co. (Global Investors) | 1.95 |
| Capital Research & Management Co. (International Investors) | 1.60 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 325’000 | 330’000 | 350’000 | 400’000 | 440’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.75 | 0.78 | 0.82 | 0.81 | 0.84 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 42’634 | 53’718 | 61’758 | 69’069 | 78’437 |
| Summe Anlagevermögen | 134’123 | 146’962 | 153’996 | 181’233 | 199’978 |
| Summe Aktiva | 176’757 | 200’680 | 215’754 | 250’302 | 278’415 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 44’637 | 48’779 | 50’276 | 62’453 | 67’435 |
| Summe Fremdkapital | 114’595 | 130’141 | 139’275 | 163’955 | 179’496 |
| Summe Eigenkapital | 62’162 | 70’539 | 76’479 | 86’347 | 98’919 |
| Summe Passiva | 176’757 | 200’680 | 215’754 | 250’302 | 278’415 |
Adresse
| 9900 Bren Road East, 55343 Minnetonka | |
| Telefon | +1 (800) 328-5979 |
| Fax | +1 (800) 936-1819 |
| URL | http://www.unitedhealthgroup.com |
Management
|
Andrew Philip Witty
Chief Executive Officer & Director |
|
Brett Manderfeld
Senior VP-Capital Markets Communications Area |
|
Brian Thompson
Chief Executive Officer-UnitedHealthcare |
|
Charles D. Baker
Independent Director |
|
Chris Zaetta
Secretary, Chief Legal Officer & Executive VP |
|
D. Ellen Wilson
Executive Vice President |
|
Dame Vivian Hunt
Chief Innovation Officer |
|
Daniel J. Schumacher
Chief Strategy & Growth Officer |
|
Deedrea Grein
Vice President-Corporate Strategy |
|
Frances Jacobs
Senior Vice President-Investor Relations |
|
Frederick William McNabb
Independent Director |
|
John Franklin Rex
President & Chief Financial Officer |
|
John H. Noseworthy
Independent Director |
|
John Walthour
Vice President-Strategic Insights |
|
Joy Fitzgerald
SVP, Chief Diversity, Equity & Inclusion Officer |
|
Kristen L. Gil
Independent Director |
|
Kristi Hummel
Chief Talent Officer |
|
Kuai H. Leong
Deputy Secretary & Senior Deputy General Counsel |
|
Larry C. Renfro
Vice Chairman |
|
Margaret-Mary Wilson
Chief Medical Officer & Executive Vice President |
|
Michele J. Hooper
Lead Independent Director |
|
Patricia L. Lewis
Chief Sustainability Officer & Executive VP |
|
Paul R. Garcia
Independent Director |
|
Richard J. Mattera
Chief Development Officer & Senior Vice President |
|
Richard J. Migliori
Executive Vice President |
|
Rupert Mark Boden Bondy
Senior Counsel, EVP-Governance & Compliance |
|
Sandeep Dadlani
Chief Digital & Technology Officer & EVP |
|
Stephanie L. Fehr
Chief Human Capital Officer & EVP-UnitedHealthcare |
|
Stephen J. Hemsley
Chairman |
|
Terry M. Clark
Chief Customer & Marketing Officer & Executive VP |
|
Thomas Edward Roos
Chief Accounting Officer & Executive VP |
|
Timothy Patrick Flynn
Independent Director |
|
Todd Walthall
Executive Vice President-Enterprise Growth |
|
Valerie C. Montgomery Rice
Independent Director |
|
Zack Sopcak
Senior Vice President-Investor Relations |